June 23, 2011 — The Heart Rhythm Society (HRS) applauds the introduction of House Resolution 295 by Reps. Kay Granger, R - Texas, Dutch Ruppersberger, D – Md., and Charles Gonzalez, D - Texas. The resolution will support efforts to raise public awareness of atrial fibrillation (AF) by enhancing the quality of care and patient safety, advancing research and education, and improving access to appropriate medical treatment for patients suffering from AF.

Jun 21, 2011 – Insurance provider UnitedHealthcare has made Cambridge Heart’s Microvolt T-Wave Alternans (MTWA) testing a covered benefit for its subscribers. UnitedHealthcare is an operating division of UnitedHealth Group, the largest single health carrier in the United States with more than 32 million medical enrollments.


June 21, 2011 – Issues involving sharing medical images and possible solutions were discussed by vendors during an Applied Vendor Learning Session at the 2011 Society of Imaging Informatics in Medicine (SIIM) annual meeting, June 2-5 in Washington, D.C.

June 21, 2011 – The Heart Hospital of Austin, a physician-led hospital specializing in the diagnosis and treatment of cardiovascular disease in Austin, Texas, recently adopted the Philips iE33 xMatrix ultrasound system with live 3-D transesophageal echo (TEE). Clinicians wanted better views of heart valves to help them diagnose and treat patients. The system was chosen for use in the hospital’s open-heart valve program.

May 16, 2011 — Patients who undergo a procedure to unblock a coronary artery are likely to survive longer if they participate in structured follow-up care, according to research in Circulation: Journal of the American Heart Association .

June 21, 2011 – The St. Francis Heart Center in Indianapolis, Ind., announced that it has performed the first post-U.S. Food and Drug Administration (FDA) approval surgery in the United States using a new device for treating tricuspid valve disease.

June 20, 2011 — Evaluating patients with multiple sclerosis who have narrowed jugular and azygos veins — and the value of widening those veins with angioplasty — warrants careful, well-designed research, noted members of a Society of Interventional Radiology Foundation's research consensus panel. The multidisciplinary panel indicated that while specific parameters for a large-scale, pivotal multicenter trial are not now available, that type of study is the "mandatory goal" in exploring a condition called chronic cerebrospinal venous insufficiency (or CCSVI).

June 20, 2011 — Randox Laboratories, the international clinical diagnostics company, has today launched an automated laboratory assay for heart-type fatty acid binding protein (H-FABP) to improve the diagnosis and management of patients with suspected acute coronary syndrome (ACS).

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now